The purpose of this contract is to provide funding for the development of a novel vaccine for foot-and-mouth disease (FMD).

Ended Definitive Contract Awarded Last action

Contract number
HSHQDC13C00018
Awardee
Awarding agency
Obligated
$194,740

Award facts

Opportunity
Contract value 38% obligated
  • $194,740.00 Current, with exercised options
  • $516,810.00 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Funding agency
Science and Technology Directorate Department of Homeland Security
NAICS code
541711 Research and Development in Biotechnology
PSC
AJ52 R&D- General Science/Technology: Life Sciences (Applied Research/Exploratory Development)
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Firm Fixed Price
Place of performance
Louisville, KY 40202, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00001 · Closeout $0
Original award $194,740

Quick answers

Who was awarded contract HSHQDC13C00018?

HSHQDC13C00018 was awarded to Apovax, Inc. by Office of Procurement Operations (Department of Homeland Security) on February 21, 2013.

How much is contract HSHQDC13C00018 worth?

The government has obligated $194,740 on HSHQDC13C00018. Its potential value, with all options, is $516,810.

Which agency awarded contract HSHQDC13C00018?

Office of Procurement Operations (Department of Homeland Security) awarded HSHQDC13C00018, with funding from Science and Technology Directorate (Department of Homeland Security).

Was contract HSHQDC13C00018 competed?

The extent of competition for HSHQDC13C00018 was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award